Novo Holdings co-leads £90 million Series A financing for Myricx Bio
The funds will be used to build out Myricx Bio’s proprietary payload platform and advance its pipeline through clinical proof of…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Imperial College London
Study finds drugs used to treat prostate cancer could help treat COVID-19
Research showed that treatment with the androgen-blocking drug enzalutamide reduced TMPRSS2 levels in lab cultures of human lung…
Antibodies against SARS-CoV-2 wane over time, suggesting immunity may be short-lived: GlobalData
Following new data from Imperial College London (ICL) suggesting that antibody levels against SARS-CoV-2 wane over time; Michael…
Research links COVID-19 to rise in childhood type 1 diabetes
This study analysed data from 30 children in London hospitals diagnosed with new-onset type 1 diabetes during the first peak of…
Greater global cooperation needed to tackle vaccine-preventable diseases in a world with COVID-19
The study included researchers from the University of Strathclyde, University of Ghana, Imperial College London, the Center for…
Swiftly waning COVID-19 immunity poses vaccination challenge
Preliminary studies in China, Germany, Britain and elsewhere have found that patients infected with the novel coronavirus make…
UK funds human trials of Imperial College London’s COVID-19 vaccine research
Robin Shattock, a professor at Imperial’s department of infectious disease, said that rather than using a part of the virus, as…
Childhood vaccines reduce antibiotic consumption in low and middle income countries
Researchers at CDDEP, Berkeley, and Imperial College London assessed the impact of PCVs and rotavirus vaccines on antibiotic…